← FDA DRUG APPROVALS
FDA ANDA · ANDA218247
DUAL ACTION
acetaminophen and ibuprofen (nsaid) tablets, 250 mg/ 125 mg
Sponsor: DR REDDYS
APPLICATION
ANDA218247
TYPE
ANDA
ORIGINAL APPROVAL
2024-08-23
LATEST ACTION
2024-08-23
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Over-the-counter
Products
ACETAMINOPHEN AND IBUPROFENOver-the-counter
ACETAMINOPHEN 250MG, IBUPROFEN 125MG · TABLET · ORAL
Approval history
2024-08-23UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.